Diabeato is the eminent provider of world’s most extensively validated Artificial Intelligence (AI) based technology for autonomous detection of diabetic retinopathy, tested on over half a million patient visits globally with over two million images collected in real-world clinical environments.
We work with Diabetologists and Ophthalmologists to collectively help over 65 million diabetic and pre-diabetic patients across the country.
We enable identification of patients with vision-threatening retinopathy in-clinic, in real-time, so they can be immediately referred to an eyecare specialist for treatment to save their sight.